Description
DCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC 50 value of 17.9 µM. DCLX069 shows less active against PRMT4 and PRMT6. DCLX069 has anticancer effectsIn VitroDCLX069 (12.5-100 µM) effectively blocks cell proliferation in breast cancer, liver cancer and acute myeloid leukemia cell lines (MCF7, HepG2, and THP1 cells) in a concentration-dependent manner. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:PRMT1 17.9 µM (IC 50 )